Extendicare (TSE:EXE – Get Free Report) received a C$15.40 price objective from equities researchers at National Bankshares in a note issued to investors on Thursday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. National Bankshares’ price target points to a potential upside of 19.29% from the stock’s previous close.
Other equities analysts have also recently issued research reports about the company. BMO Capital Markets raised their price target on Extendicare from C$13.50 to C$14.50 in a report on Monday, May 12th. TD Securities raised their target price on shares of Extendicare from C$13.00 to C$15.00 and gave the company a “hold” rating in a report on Thursday, May 22nd. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of C$13.98.
View Our Latest Analysis on Extendicare
Extendicare Trading Down 2.4%
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- What Does Downgrade Mean in Investing?
- Why Pure Storage Is a Core Investment for the AI Era
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- Earnings Per Share Calculator: How to Calculate EPS
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.